Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 5, 2018

Total Value ($000): $138,312 (100.0% shares, 0.0% debt)

Holdings (12)

— Paratek Pharmaceuticals 33.7%

Value ($000) $46,547 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Juno Therapeutics 24.9%

Value ($000) $34,445 Shares 753,564 Est. Cost $52.22 Unrealized —

SNNAQ Sienna Biopharmaceuticals 10.0%

Value ($000) $13,769 Shares 758,610 Est. Cost $21.95 Unrealized -3.6%

— ObsEva 7.1%

Value ($000) $9,760 Shares 1,000,000 Est. Cost $9.76 Unrealized —

— Jounce Therapeutics 5.3%

Value ($000) $7,391 Shares 579,650 Est. Cost $21.99 Unrealized —

— Pieris Pharmaceuticals 4.9%

Value ($000) $6,826 Shares 904,053 Est. Cost $1.83 Unrealized —

— FibroGen 4.5%

Value ($000) $6,193 Shares 130,646 Est. Cost $27.34 Unrealized —

— CymaBay Therapeutics 3.7%

Value ($000) $5,074 Shares 551,477 Est. Cost $4.71 Unrealized —

— Cidara Therapeutics 2.2%

Value ($000) $3,026 Shares 444,965 Est. Cost $10.40 Unrealized —

— Egalet 2.1%

Value ($000) $2,890 Shares 2,889,926 Est. Cost $5.98 Unrealized —

— Dicerna Pharmaceuticals 1.5%

Value ($000) $2,018 Shares 223,457 Est. Cost $16.47 Unrealized —

— ESSA Pharma 0.3%

Value ($000) $373 Shares 1,696,969 Est. Cost $5.22 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Paratek Pharmaceuticals	2,600,410	$46,547	33.7%	$34.18	—	Common Stock	699374302
—	Juno Therapeutics	753,564	$34,445	24.9%	$52.22	—	Common Stock	48205A109
SNNAQ	Sienna Biopharmaceuticals	758,610	$13,769	10.0%	$21.95	-3.6%	Common Stock	82622H108
—	ObsEva	1,000,000	$9,760	7.1%	$9.76	—	Common Stock	H5861P103
—	Jounce Therapeutics	579,650	$7,391	5.3%	$21.99	—	Common Stock	481116101
—	Pieris Pharmaceuticals	904,053	$6,826	4.9%	$1.83	—	Common Stock	720795103
—	FibroGen	130,646	$6,193	4.5%	$27.34	—	Common Stock	31572Q808
—	CymaBay Therapeutics	551,477	$5,074	3.7%	$4.71	—	Common Stock	23257D103
—	Cidara Therapeutics	444,965	$3,026	2.2%	$10.40	—	Common Stock	171757107
—	Egalet	2,889,926	$2,890	2.1%	$5.98	—	Common Stock	28226B104
—	Dicerna Pharmaceuticals	223,457	$2,018	1.5%	$16.47	—	Common Stock	253031108
—	ESSA Pharma	1,696,969	$373	0.3%	$5.22	—	Common Stock	29668H104